You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Medtronic
Mallinckrodt
Harvard Business School
Express Scripts

Last Updated: September 26, 2020

DrugPatentWatch Database Preview

Patent: 9,855,284

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,855,284
Title:Pharmaceutical compositions and methods
Abstract: This invention relates the use of cortisol blockers (e.g., glucocorticoid receptor [GR] antagonists) for the treating or preventing viral infections, treating or preventing treatment resistant prostate cancer, treating or preventing neoplasia, and treating or preventing infection related to acute or chronic injury or disease.
Inventor(s): Altschul; Randice Lisa (Cliffside Park, NJ), Theise; Neil David (New York, NY), Kesel; Andreas J. (Munich, DE), Rapkin; Myron (Indianapolis, IN), O\'Brien; Rebecca (Shell Knob, MO), Arment; Anthony R. (Fairborn, OH)
Assignee: Pop Test Oncology LLC (Cliffside Park, NJ)
Application Number:15/370,680
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,855,284
Patent Claims:see list of patent claims

Details for Patent 9,855,284

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Hoffman-la Roche PEGASYS peginterferon alfa-2a VIAL; SUBCUTANEOUS 103964 001 2002-10-16   Start Trial Pop Test Oncology LLC (Cliffside Park, NJ) 2035-08-03 RX search
Hoffman-la Roche PEGASYS peginterferon alfa-2a SYRINGE 103964 002 2002-10-16   Start Trial Pop Test Oncology LLC (Cliffside Park, NJ) 2035-08-03 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Moodys
Boehringer Ingelheim
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.